GLUE SCHEDULE 13G/A: SEC filing

TCG Crossover entities and Chen Yu

Filed with the SEC on · accession 0001193125-26-464030

GLUE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.2% by the first close after the filing.

Summary of the filing

TCG Crossover entities and Chen Yu filed an amended Schedule 13G reporting beneficial ownership of approximately 3,781,532 shares, or 4.4%, of Monte Rosa Therapeutics common stock as of September 30, 2026.

Key details

Shares of common stock beneficially owned by Chen Yu (aggregate)$3.8M
Shares held by TCG Crossover Fund II, L.P.$1.9M
Shares held by TCG Crossover Fund III, L.P.$1.9M
IssuerMonte Rosa Therapeutics, Inc.
Reporting person / holder of 1,890,766 sharesTCG Crossover Fund II, L.P.
General partner of tcg crossover fund iiTCG Crossover GP II, LLC
Reporting person / holder of 1,890,766 sharesTCG Crossover Fund III, L.P.
General partner of tcg crossover fund iiiTCG Crossover GP III, LLC
Sole managing member of tcg crossover gp ii and gp iiiChen Yu

How GLUE stock reacted

Close before

$9.37

Nov 13, 2026

First close after

-2.24%

$9.16

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GLUE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GLUE?

Click here

Frequently asked questions

What did GLUE file with the SEC on Nov 16, 2026?

GLUE filed a SCHEDULE 13G/A (SEC filing). TCG Crossover entities and Chen Yu filed an amended Schedule 13G reporting beneficial ownership of approximately 3,781,532 shares, or 4.4%, of Monte Rosa Therapeutics common stock as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did GLUE stock react to this filing?

GLUE closed at $9.37 before the filing and $9.16 on Nov 16, 2026 (-2.24%).

Other GLUE SEC filings

Get alerts when GLUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days